NCT01950533已完成不适用
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 102
- 试验地点
- 1
- 主要终点
- Relationship between food specific IgEs
研究概览
简要总结
Food allergy is on the rise within the pediatric population. Having food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Skin prick testing and food-specific IgE testing of the blood can give positive results that are false. Currently, Oral Food Challenges are the best way to diagnose a food allergy. Unfortunately, Oral Food Challenges are time consuming and may not be readily available to suspected food allergy sufferers. This study is designed to examine the effectiveness of an allergy-detecting blood test called IMMULITE 2000 manufactured by the study sponsor, Siemens.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 3 Years 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 3 to 21 years of either sex and any race
- •Physician-diagnosed food allergy or convincing clinical history of food allergy to milk, egg, and/or peanut AND a Skin prick test positive to milk, egg, and/or peanut (diameter of wheal > 3 mm or greater than negative control) orOR a detectable serum food-specific IgE level (ImmunoCAP and/or IMMULITE > 0.35 kUA/L) to milk, egg, and/or peanut
- •If no history of clinical reactivity to milk, egg, or peanut, then a positive skin prick test to milk, egg, and/or peanut (diameter of wheal > 3 mm or greater than negative control) OR a detectable serum food-specific IgE level within the previous 4 months to milk, egg, and/or peanut
- •Written informed consent from parent/guardian and assent (when age appropriate).
- •Willingness to submit specimen for laboratory serum IgE testing
排除标准
- •Inability to discontinue antihistamines for skin prick testing and OFCs
- •Current allergy to placebo ingredient (oat flour) OR reaction to any dose of placebo at the qualifying OFC
- •FEV1 value <80% predicted OR any clinical features of moderate or severe persistent asthma, as defined by the 2007 NHLBI guidelines table for classifying asthma baseline severity (Step 3 or above), at the time of entry into the study
- •Use of , and >high medium daily doses of inhaled corticosteroids, as defined by the 2007 NHLBI guidelines inhaled corticosteroid dosing table (500500 μg/day fluticasone or equivalents for an adult) or a long acting beta-agonist (LABA) to control asthma.
- •Asthma requiring either:
- •> 1 hospitalization in the past year for asthma or > 1 ER visit in the past 6 months for asthma
- •History of intubation due to allergies or asthma
- •Use of steroid medications (IV, IM or oral) for asthma in the following manners:
- •history of daily oral steroid dosing for >1 month during the past year or
- •burst or steroid course/burst in the past 3 months or
- •>2 burst oral steroid courses/bursts in the past year
- •History of intubation due to allergies or asthma
- •Life-threatening allergic reaction (e.gi.e., respiratory compromise, hypoxia, hypotension, use of epinephrine) to study food(s) (e.g., milk, egg, and/or peanut) within last 1 year
- •Diagnosis of active eosinophilic gastrointestinal disease in the past year
- •Severe or poorly controlled atopic dermatitis, as assessed by a three-item severity (TIS) score of 6 or greater (see Appendix I)
- •Use of omalizumab or other non-traditional forms of allergen immunotherapy (e.g., oral or sublingual), immunomodulatory therapy (not including corticosteroids), or biologic therapy within the past year
- •Uncontrolled hypertension
- •Any use of β-blockers (oral), angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB) or calcium channel blockers
- •Other significant medical conditions (e.g., liver, gastrointestinal, kidney, cardiovascular, pulmonary disease, or blood disorders), which, in the opinion of the Investigator, make the subject unsuitable for induction of food reactions
- •Pregnancy
结局指标
主要结局
Relationship between food specific IgEs
时间窗: approximately 2 weeks
To determine the relationship between food-specific IgE to whole proteins of milk, egg, and peanut using the IMMULITE 2000 assay and OFC outcomes.
次要结局
- Logisitic regression analyses on data(approximately 2 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenRhinitis, AllergicAsthma, AllergicConjunctivitis, AllergicAtopic DermatitisChronic UrticariaNCT06063044Second Affiliated Hospital, School of Medicine, Zhejiang University407
终止
不适用
Evaluation of Potential Allergenicity of New Soybean VarietiesSoy AllergyNCT01950559University of Colorado, Denver10
已完成
不适用
The Effect of Per Oral Immunotherapy in Severe IgE Mediated Egg, Milk, and Nut Allergy in AdultsFood AllergyNCT01822353Helsinki University Central Hospital23
终止
不适用
Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin CareWheat AllergyChildrenNCT04013763Mahidol University7
已完成
不适用
Potential Role of AGEs in Paediatric AllergiesAllergyNCT04273152Federico II University200